TipRanks
Steris plc (STE)
NYSE:STE
US Market
Want to see STE full AI Analyst Report?

Steris (STE) Revenue by Type

440 Followers

Revenue by Type

Separates revenue into types such as capital equipment, consumables, and recurring service contracts, showing how much revenue is predictable versus one‑off. That mix influences cash flow stability and how analysts should value the company.
Steris has shown robust growth in service revenue, maintaining a steady upward trajectory. However, consumable revenue experienced a sharp drop in early 2024, likely due to inventory adjustments or market shifts, before stabilizing. Capital equipment revenue faced challenges, aligning with the earnings call's note on a 5% decline in healthcare capital equipment revenue. Despite these hurdles, the company remains optimistic, projecting 6% to 7% revenue growth in fiscal 2026, driven by strategic pricing and productivity improvements, even as they navigate tariff costs and legal settlements.
Date
Service
Consumable
Capital Equipment
Jun 30, 2026
$756.20M$473.40M$263.20M
Mar 31, 2026
$741.50M$459.80M$387.20M
Dec 31, 2025
$717.60M$463.00M$315.60M
Sep 30, 2025
$715.30M$451.40M$293.40M
Jun 30, 2025
$701.40M$434.20M$255.50M
Mar 31, 2025
$679.45M$429.99M$371.08M
Dec 31, 2024
$652.23M$427.47M$290.87M
Sep 30, 2024
$633.00M$414.36M$281.55M
Jun 30, 2024
$623.21M$414.09M$242.20M
Mar 31, 2024
$633.15M$100.40M$382.60M